Arcadia Biosciences, Inc. ( RKDA) - Key Metrics
RKDA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.57 | -$2.47 | -$0.13 | -$0.13 |
| 2026Q1 | $0.80 | -$3.21 | -$0.80 | -$0.80 |
| 2025Q4 | $0.66 | -$0.98 | -$0.63 | -$0.63 |
| 2025Q3 | $0.95 | $0.63 | -$0.19 | -$0.19 |
| 2025Q2 | $1.06 | -$3.26 | -$1.49 | -$1.49 |
RKDA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.08 |
| 2026Q1 | 0% | -0.11 |
| 2025Q4 | 0% | -0.51 |
| 2025Q3 | 0% | 1.38 |
| 2025Q2 | 0% | -0.33 |
RKDA
Price: $0.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.54 USD
Exchange: NCM
Sector: Consumer Defensive
Industry: Packaged Foods
Country: United States
Volume: 191500
Ebitda: -4.4 millionMarket Capitalization: 729560